Vator Securities advises Respiratorius on 25 MSEK Directed Share Issue
Vator Securities acts as Financial Adviser in connection with the transaction raising SEK 25 million.
Respiratorius AB is developing drug candidates with the goal to launch drugs for common diseases cancer, chronic obstructive pulmonary disease (COPD) and severe asthma. In addition, the project portfolio is a project for improved diagnosis of certain cardiovascular diseases.
Read More
Vator Securities advises Sprint Bioscience on 21 MSEK Directed Share Issue
Vator Securities acts as Financial Adviser in connection with the transaction raising SEK 21 million.
Sprint Bioscience develops small-molecule first-in-class drug projects with a focus on oncology. With a fragment-based drug development method, the company develops drug projects in a time- and resource-efficient way that is outlicensed to global pharmaceutical companies during the preclinical phase.
Read More
Vator Securities advises Epulze on 57 MSEK Private Placement
Vator Securities acts as Financial Adviser in connection with the transaction raising SEK 57 million.
Epulze gives amateur players of computer games like Dota 2 and Counter-Strike: Global Offensive, the opportunity to participate in tournaments, leagues, and matches where real money is at stake. Among the new investors are well-known names such as Svea Ekonomi and Norwegian Carucel Finance, while Knutsson Holdings increases its ownership in the company.
Read More
Vator Securities advises CombiGene on 75 MSEK Rights Issue
Vator Securities acts as Financial Adviser in connection with the transaction raising approximately SEK 75 million.
Having established the production platform for CG01, CombiGene’s intention in 2021 is to focus on the final parts of the preclinical program for CG01 with two major preclinical studies, a biodistribution study and a safety study, which will be conducted together with CombiGene’s CRO partners Northern Biomedical Research and Neurochase.
Read More
Vator Securities Events
Vator Securities Tech Days are investor events with some of the most interesting and fast-growing tech companies in the Nordics.
Vator Securities presents a focused insight into the spectrum of tech companies including expert sessions related to the tech industry.
Read More
IBD Junior Analyst – Corporate Finance till Vator Securities
Som junior analytiker kommer fokus ligga på att assistera dina kollegor vid framtagandet av företagspresentationer, arbeta med research, samt bistå med administration kring transaktioner och projekt.
Teamet består idag av 9 personer och kommer att utökas med ytterligare juniora talanger.
Read More
Ett digitalt seminarium i samarbete med Hallvarsson & Halvarsson – 20 januari 2021
Vator Securities i samarbete med Hallvarsson & Halvarsson har nöjet att bjuda in till ett kostnadsfritt digitalt seminarium i hur ni kan arbeta proaktivt för att utbilda marknaden om er Equity Story, samt hur ni hanterar informationsgivningen i enlighet med börsregelverket och MAR.
Seminariet arrangeras onsdag den 20 januari 2021 mellan klockan 10:00-11:00.
Read More
Vator Securities advises SiB Solutions on 23 MSEK Private Placement
Vator Securities acts as Financial Adviser in connection with the transaction raising SEK 23 million.
SiB Solutions offers a software for video content analytics that provides efficient monitoring and analysis of logistics processes to minimize shrinkage in the supply chain. The value of goods lost in logistics processes globally is estimated at around EUR 10 billion each month, with consequential costs of around EUR 20 billion.
Read More